After a highly lauded research campaign that successfully redesigned a hepatitis C drug into one of the leading drug treatments for COVID-19, scientists at the Department of Energy’s Oak Ridge National Laboratory are now turning their drug design approach toward cancer.
Click here for original story, Neutrons seek to stop cancer from hijacking a metabolic highway
Source: Phys.org